Collected Dataset / ICoVVaC_CohortB_4weeks_postdose4

ICoVVaC_CohortB_4weeks_postdose4
  1. Home
  2. Collected Datasets
  3. ICoVVaC_CohortB_4weeks_postdose4

ICoVVaC_CohortB_4weeks_postdose4

Networks -
Variables -
Associated study ICoVVaC Contingency Table

Population

ICoVVaC - Cohort B
The population is composed of cancer patients with solid tumours from cancer clinics at the Ottawa Hospital and at Vancouver BC Cancer, who were not on chemotherapy and who are going to receive COVID-19 vaccination as part of the national vaccine roll-out (standard of care) and included in the study within 4 weeks of the second dose of vaccine.
More info

Data Collection Event

ICoVVaC - Cohort B - 4 weeks post-dose 4
Information on demographics, vaccine details, assessment of clinical outcomes (incidence of COVID-19) and patient self-reported COVID-19 testing results was collected. Blood samples (serum and peripheral blood mononuclear cells (PBMCs)) were collected.
More info